Development, Optimization & Evaluation of Porous Chitosan Scaffold Formulation of Gliclazide for the Treatment of Type-2 Diabetes Mellitus

Author： Garg Tarun   Murthy R.S.R.   Kumar Goyal Amit   Arora Saahil   Malik Basant  

Publisher： Bentham Science Publishers

ISSN： 2210-3031

Source： Drug Delivery Letters, Vol.2, Iss.4, 2012-12, pp. : 251-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Development, Optimization & Evaluation of Porous Chitosan Scaffold Formulation of Gliclazide for the Treatment of Type-2 Diabetes Mellitus

By  

Drug Delivery Letters, Vol. 2, Iss. 4, 2012-12 ,pp. : 251-261

Bentham Science Publishers

Access to resources Recommend Favorite

Repaglinide and gliclazide are equally effective when combined with bedtime insulin in patients with type 2 diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1419, 2004-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Orlistat: In the Prevention and Treatment of Type 2 Diabetes Mellitus

By Keating G.M.   Jarvis B.  

Drugs, Vol. 61, Iss. 14, 2001-01 ,pp. : 2107-2119

Adis International

Access to resources Recommend Favorite

Meglitinide Analogues in the Treatment of Type 2 Diabetes Mellitus

By Landgraf R.  

Drugs & Aging, Vol. 17, Iss. 5, 2000-11 ,pp. : 411-425

Adis International

Access to resources Recommend Favorite

Orlistat in the treatment of Type 2 diabetes mellitus

By Jneidi Muna   Kelley David E  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 5, 2002-05 ,pp. : 599-605

Informa Healthcare

Access to resources Recommend Favorite